1.A study on the effect of irregular hepatectomy combined with placing pump inside hepatic artery for the treatment of hepatic cancer
Hongliang ZHANG ; Songzhen ZHENG ; Xingcai GAO
Chinese Journal of Minimally Invasive Surgery 2001;0(04):-
Objective To evaluate the effects of irregular hepatectomy combined with chemotherapy by placing pump inside hepatic artery on the postoperative recurrence rate and the postoperative survival rate. Methods The clinical data of 66 cases of hepatic cancer treated in the last 15 years were reviewed. 48 cases out of 66 cases were treated with simple hepatectomy and 18 cases with hepatectomy combined with chemotherapy by placing pump inside hepatic artery. Results There was a significant diference in the 1 year or 3 years or 5 years recurrence rate which were 66.7% to 38.9%, 85.4% to 55.6%, 93.8% to 72.2%, respectively in simple hepatectomy group and operation-chemotherapy group ( P
2.Lipid nanomaterials-based RNA therapy and cancer treatment.
Xingcai ZHANG ; Luo HAI ; Yibo GAO ; Guocan YU ; Yingli SUN
Acta Pharmaceutica Sinica B 2023;13(3):903-915
We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology.